Skip to content

Cineverse Corp. CNVS Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

MGN
MagniteMGNI
$26K-89.7%
Teads Holding Co. Common Stock logo
Teads Holding Co. Common StockTEAD
$0-100%
Netflix logo
NetflixNFLX
$49.31M-86.0%
DJT
Trump Media & Technology GroupDJT
$11.83M-33.7%
CSP logo
CSPCSPI
$187K-2.1%
Angel Studios, Inc. logo
Angel Studios, Inc.ANGX
$0-100%

Other financials

Income statement

See full
Revenue$26.0M+66.7%
Gross profit$13.8M
Operating income-$5.4M-353%
Net income-$875.0K-112%
EPS (diluted)-$0.05-115%

Balance sheet

See full
Cash & equivalents$3.4M-75.7%
Total debt$403.0K-12.8%
Total equity$44.3M+14.4%
Total assets$130.3M+79.7%

Cash flow

See full
Operating cash flow-$3.2M-126%
CapEx$267.3K-68.3%
Free cash flow-$2.9M-67.8%

Valuation

See full
Market cap$69.55M+3.4%
Enterprise value$66.56M+1.3%
P/S1.1×+0.2×

Profitability

See full
Gross margin98.5%
Operating margin-23.1%-33.2pp
Net margin-16.4%+0.2pp
FCF margin-23.7%+36.2pp

Returns & leverage

See full
Return on equity-23.9%-3.4pp
Debt / equity0.0×
Current ratio0.8×-0.3×

Where this comes from

Reported directly by Cineverse Corp. in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfCommonStock.

The official record: Cineverse Corp.’s 10-K, filed June 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cineverse Corp.'s stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cineverse Corp.'s stock issuance proceeds?
Cineverse Corp. (CNVS) reported stock issuance proceeds of $1.51M in Q1 2026.
What is the long-term trend for Cineverse Corp.'s stock issuance proceeds?
Over 2 years (2022 to 2026), Cineverse Corp.'s stock issuance proceeds has grown at a -47.2% compound annual growth rate (CAGR), from $12.38M to $3.45M.
What does stock issuance proceeds mean?
Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.